My NCBI | Sign In
RSS Settings
  • Search: Baser ME[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 69

    1.

    Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.

    Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG.

    J Clin Oncol. 2006 Jun 1;24(16):2570-5.PMID: 16735710 [PubMed - indexed for MEDLINE]Related articles

    2.

    Increasing the specificity of diagnostic criteria for schwannomatosis.

    Baser ME, Friedman JM, Evans DG.

    Neurology. 2006 Mar 14;66(5):730-2.PMID: 16534111 [PubMed - indexed for MEDLINE]Related articles

    3.

    The distribution of constitutional and somatic mutations in the neurofibromatosis 2 gene.

    Baser ME; Contributors to the International NF2 Mutation Database.

    Hum Mutat. 2006 Apr;27(4):297-306. Review.PMID: 16521120 [PubMed - indexed for MEDLINE]Related articles

    4.

    Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation.

    Baser ME, Rai H, Wallace AJ, Evans DG.

    Fam Cancer. 2005;4(4):321-2.PMID: 16341811 [PubMed - indexed for MEDLINE]Related articles

    5.

    Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes.

    Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME.

    J Med Genet. 2006 Apr;43(4):289-94. Epub 2005 Sep 9. Review.PMID: 16155191 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Management of the patient and family with neurofibromatosis 2: a consensus conference statement.

    Evans DG, Baser ME, O'Reilly B, Rowe J, Gleeson M, Saeed S, King A, Huson SM, Kerr R, Thomas N, Irving R, MacFarlane R, Ferner R, McLeod R, Moffat D, Ramsden R.

    Br J Neurosurg. 2005 Feb;19(1):5-12. Review.PMID: 16147576 [PubMed - indexed for MEDLINE]Related articles

    7.

    Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.

    Evans DG, Maher ER, Baser ME.

    J Med Genet. 2005 Aug;42(8):630-2.PMID: 16061561 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

    Baser ME, Kuramoto L, Woods R, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Olschwang S, Bijlsma E, Kalamarides M, Papi L, Kato R, Carroll J, Lázaro C, Joncourt F, Parry DM, Rouleau GA, Evans DG.

    J Med Genet. 2005 Jul;42(7):540-6. Review.PMID: 15994874 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma.

    Baser ME, Poussaint TY.

    J Med Genet. 2006 Mar;43(3):285-7. Epub 2005 Jun 24.PMID: 15980114 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Methodological issues in longitudinal studies: vestibular schwannoma growth rates in neurofibromatosis 2.

    Baser ME, Mautner VF, Parry DM, Evans DG.

    J Med Genet. 2005 Dec;42(12):903-6. Epub 2005 Apr 14. Review.PMID: 15831594 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Multiple meningiomas: differential involvement of the NF2 gene in children and adults.

    Evans DG, Watson C, King A, Wallace AJ, Baser ME.

    J Med Genet. 2005 Jan;42(1):45-8.PMID: 15635074 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.

    Tsilchorozidou T, Menko FH, Lalloo F, Kidd A, De Silva R, Thomas H, Smith P, Malcolmson A, Dore J, Madan K, Brown A, Yovos JG, Tsaligopoulos M, Vogiatzis N, Baser ME, Wallace AJ, Evans DG.

    J Med Genet. 2004 Jul;41(7):529-34. Review. No abstract available. PMID: 15235024 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.

    Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Gillespie JE, Ramsden RT, Evans DG.

    Am J Hum Genet. 2004 Aug;75(2):231-9. Epub 2004 Jun 9.PMID: 15190457 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.

    Warren C, James LA, Ramsden RT, Wallace A, Baser ME, Varley JM, Evans DG.

    J Med Genet. 2003 Nov;40(11):802-6.PMID: 14627667 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Evaluation of genotype-phenotype correlations in neurofibromatosis type 1.

    Castle B, Baser ME, Huson SM, Cooper DN, Upadhyaya M.

    J Med Genet. 2003 Oct;40(10):e109. No abstract available. PMID: 14569132 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Genotype-phenotype correlations for cataracts in neurofibromatosis 2.

    Baser ME, Kuramoto L, Joe H, Friedman JM, Wallace AJ, Ramsden RT, Evans DG.

    J Med Genet. 2003 Oct;40(10):758-60. No abstract available. PMID: 14569124 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring.

    Moyhuddin A, Baser ME, Watson C, Purcell S, Ramsden RT, Heiberg A, Wallace AJ, Evans DG.

    J Med Genet. 2003 Jun;40(6):459-63. No abstract available. PMID: 12807969 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Exploring the "two-hit hypothesis" in NF2: tests of two-hit and three-hit models of vestibular schwannoma development.

    Woods R, Friedman JM, Evans DG, Baser ME, Joe H.

    Genet Epidemiol. 2003 May;24(4):265-72.PMID: 12687643 [PubMed - indexed for MEDLINE]Related articles

    19.

    Neurofibromatosis 2.

    Baser ME, R Evans DG, Gutmann DH.

    Curr Opin Neurol. 2003 Feb;16(1):27-33. Review.PMID: 12544854 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evaluation of clinical diagnostic criteria for neurofibromatosis 2.

    Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG.

    Neurology. 2002 Dec 10;59(11):1759-65.PMID: 12473765 [PubMed - indexed for MEDLINE]Related articles

    21.

    Intrafamilial correlation of clinical manifestations in neurofibromatosis 2 (NF2).

    Zhao Y, Kumar RA, Baser ME, Evans DG, Wallace A, Kluwe L, Mautner VF, Parry DM, Rouleau GA, Joe H, Friedman JM.

    Genet Epidemiol. 2002 Oct;23(3):245-59.PMID: 12384977 [PubMed - indexed for MEDLINE]Related articles

    22.

    Predictors of the risk of mortality in neurofibromatosis 2.

    Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, Evans DG.

    Am J Hum Genet. 2002 Oct;71(4):715-23. Epub 2002 Aug 22.PMID: 12235555 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Neurofibromatosis 2 and malignant mesothelioma.

    Baser ME, De Rienzo A, Altomare D, Balsara BR, Hedrick NM, Gutmann DH, Pitts LH, Jackler RK, Testa JR.

    Neurology. 2002 Jul 23;59(2):290-1.PMID: 12136076 [PubMed - indexed for MEDLINE]Related articles

    24.

    Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

    Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A.

    J Med Genet. 2002 May;39(5):311-4.PMID: 12011145 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.

    Mautner VF, Baser ME, Thakkar SD, Feigen UM, Friedman JM, Kluwe L.

    J Neurosurg. 2002 Feb;96(2):223-8.PMID: 11838794 [PubMed - indexed for MEDLINE]Related articles

    26.

    Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.

    Baser ME, Makariou EV, Parry DM.

    J Neurosurg. 2002 Feb;96(2):217-22.PMID: 11838793 [PubMed - indexed for MEDLINE]Related articles

    27.

    Maternal gene effect in neurofibromatosis 2: fact or artefact?

    Baser ME, Friedman JM, Evans GR.

    J Med Genet. 2001 Nov;38(11):783-4. No abstract available. PMID: 11732488 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).

    Evans DG, Newton V, Neary W, Baser ME, Wallace A, Macleod R, Jenkins JP, Gillespie J, Ramsden RT.

    J Med Genet. 2000 Dec;37(12):944-7. No abstract available. PMID: 11186935 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH.

    Bruder CE, Hirvelä C, Tapia-Paez I, Fransson I, Segraves R, Hamilton G, Zhang XX, Evans DG, Wallace AJ, Baser ME, Zucman-Rossi J, Hergersberg M, Boltshauser E, Papi L, Rouleau GA, Poptodorov G, Jordanova A, Rask-Andersen H, Kluwe L, Mautner V, Sainio M, Hung G, Mathiesen T, Möller C, Pulst SM, Harder H, Heiberg A, Honda M, Niimura M, Sahlén S, Blennow E, Albertson DG, Pinkel D, Dumanski JP.

    Hum Mol Genet. 2001 Feb 1;10(3):271-82.PMID: 11159946 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Lack of sex-ratio distortion in neurofibromatosis 2.

    Baser ME, Evans DG.

    Am J Med Genet. 2000 Nov 27;95(3):292. No abstract available. PMID: 11102942 [PubMed - indexed for MEDLINE]Related articles

    31.

    Advances in neurofibromatosis 2 (NF2): a workshop report.

    Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, Beebe D, Brackmann DE, Chiocca EA, Fehon RG, Giovannini M, Glazer R, Gusella JF, Gutmann DH, Korf B, Lieberman F, Martuza R, McClatchey AI, Parry DM, Pulst SM, Ramesh V, Ramsey WJ, Ratner N, Rutkowski JL, Ruttledge M, Weinstein DE.

    J Neurogenet. 2000 Jun;14(2):63-106. Review. No abstract available. PMID: 10992163 [PubMed - indexed for MEDLINE]Related articles

    32.

    Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2.

    Baser ME, Wallace AJ, Strachan T, Evans DG.

    J Med Genet. 2000 Jul;37(7):542-3. No abstract available. PMID: 10970189 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Detection of novel NF2 mutations by an RNA mismatch cleavage method.

    Faudoa R, Xue Z, Lee F, Baser ME, Hung G.

    Hum Mutat. 2000;15(5):474-8.PMID: 10790209 [PubMed - indexed for MEDLINE]Related articles

    34.

    Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.

    Hung G, Faudoa R, Baser ME, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D.

    Cancer Genet Cytogenet. 2000 Apr 15;118(2):167-8.PMID: 10748301 [PubMed - indexed for MEDLINE]Related articles

    35.

    Neurofibromatosis 2, radiosurgery and malignant nervous system tumours.

    Baser ME, Evans DG, Jackler RK, Sujansky E, Rubenstein A.

    Br J Cancer. 2000 Feb;82(4):998. No abstract available. PMID: 10732777 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    NF2 in monozygotic twins.

    Baser ME.

    Surg Neurol. 2000 Jan;53(1):95-6. No abstract available. PMID: 10697244 [PubMed - indexed for MEDLINE]Related articles

    37.

    Neurofibromatosis type 2.

    Evans DG, Sainio M, Baser ME.

    J Med Genet. 2000 Dec;37(12):897-904. Review. Erratum in: J Med Genet 2001 Oct;38(10):727a. PMID: 11106352 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Association of superficial plexiform and paraspinal neurofibromas in neurofibromatosis 1 (NF1)

    Baser ME, Birch PH, Evans GR, Friedman JM.

    Neurology. 1999 Apr 22;52(7):1519-20. No abstract available. PMID: 10227658 [PubMed - indexed for MEDLINE]Related articles

    39.

    Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities.

    Baser ME, Kluwe L, Mautner VF.

    Am J Hum Genet. 1999 Apr;64(4):1230-3. No abstract available. PMID: 10090912 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Skin abnormalities in neurofibromatosis 2.

    Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J.

    Arch Dermatol. 1997 Dec;133(12):1539-43.PMID: 9420538 [PubMed - indexed for MEDLINE]Related articles

    41.

    Immunohistochemical detection of schwannomin and neurofibromin in vestibular schwannomas, ependymomas and meningiomas.

    Huynh DP, Mautner V, Baser ME, Stavrou D, Pulst SM.

    J Neuropathol Exp Neurol. 1997 Apr;56(4):382-90.PMID: 9100669 [PubMed - indexed for MEDLINE]Related articles

    42.

    The ocular presentation of neurofibromatosis 2.

    Ragge NK, Baser ME, Riccardi VM, Falk RE.

    Eye (Lond). 1997;11 ( Pt 1):12-8.PMID: 9246269 [PubMed - indexed for MEDLINE]Related articles

    43.

    Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations.

    Baser ME, Mautner VF, Ragge NK, Nechiporuk A, Riccardi VM, Klein J, Sainz J, Pulst SM.

    Neurology. 1996 Nov;47(5):1269-77.PMID: 8909442 [PubMed - indexed for MEDLINE]Related articles

    44.

    Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.

    Kluwe L, Bayer S, Baser ME, Hazim W, Haase W, Fünsterer C, Mautner VF.

    Hum Genet. 1996 Nov;98(5):534-8. Erratum in: Hum Genet 1997 Feb;99(2):292. PMID: 8882871 [PubMed - indexed for MEDLINE]Related articles

    45.

    Phenotypic variability in monozygotic twins with neurofibromatosis 2.

    Baser ME, Ragge NK, Riccardi VM, Janus T, Gantz B, Pulst SM.

    Am J Med Genet. 1996 Sep 6;64(4):563-7.PMID: 8870923 [PubMed - indexed for MEDLINE]Related articles

    46.

    A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes.

    Scoles DR, Baser ME, Pulst SM.

    Neurology. 1996 Aug;47(2):544-6.PMID: 8757035 [PubMed - indexed for MEDLINE]Related articles

    47.

    Phenotypic variability in two families with novel splice-site and frameshift NF2 mutations.

    Mautner VF, Baser ME, Kluwe L.

    Hum Genet. 1996 Aug;98(2):203-6.PMID: 8698343 [PubMed - indexed for MEDLINE]Related articles

    48.

    The neuroimaging and clinical spectrum of neurofibromatosis 2.

    Mautner VF, Lindenau M, Baser ME, Hazim W, Tatagiba M, Haase W, Samii M, Wais R, Pulst SM.

    Neurosurgery. 1996 May;38(5):880-5; discussion 885-6.PMID: 8727812 [PubMed - indexed for MEDLINE]Related articles

    49.

    Identification of three neurofibromatosis type 2 (NF2) gene mutations in vestibular schwannomas.

    Sainz J, Figueroa K, Baser ME, Pulst SM.

    Hum Genet. 1996 Jan;97(1):121-3.PMID: 8557252 [PubMed - indexed for MEDLINE]Related articles

    50.

    Ocular abnormalities in neurofibromatosis 2.

    Ragge NK, Baser ME, Klein J, Nechiporuk A, Sainz J, Pulst SM, Riccardi VM.

    Am J Ophthalmol. 1995 Nov;120(5):634-41.PMID: 7485365 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    23 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity